ArticleBMC nephrology2025

BCR-ABL tyrosine kinase inhibitors associated acute kidney injury: a pharmacovigilance study based on the FAERS database with a case report.

Yanni Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.